Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

Roche begins screening for obesity drug candidates

July 19, 1996

C-Maf T-cell switch factor: Important component of Boston Life Science's R&D

July 19, 1996

Genome Therapeutics and Merck & Co. sign licensing agreement

July 19, 1996

Roche licenses PCR technology to Immuno

July 12, 1996

GenPharm describes high-affinity human IgG monoclonal antibodies

July 12, 1996

LCR Technology covered under U.S. patent

July 12, 1996

SmithKline Beecham/Human Genome Sciences human genome collaboration no longer exclusive

July 12, 1996

Oculex receives grants for ocular drug delivery research

July 12, 1996

Heliosynthese and Scotia receive EEC Eureka award for microalgae research

July 12, 1996

Phytera and Tsumura Juntendo collaborate in rheumatoid arthritis/allergy R&D

July 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.